Optimization of animal models to better predict influenza vaccine efficacy (VA).

Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Y.K. has received speaker’s honoraria from Toyama Chemical and Astellas, Inc.; grant support from Daiichi Sankyo Pharmaceutical, Toyama Chemical, Shionogi & Co., Ltd., and Kyoritsu Seiyaku; and is a founder of FluGen. G.N. is a founder of FluGen.